SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-187525
Filing Date
2021-06-10
Accepted
2021-06-10 11:51:35
Documents
12
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d168140d8k.htm   iXBRL 8-K 39136
  Complete submission text file 0001193125-21-187525.txt   163550

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210609.xsd EX-101.SCH 3102
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210609_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210609_pre.xml EX-101.PRE 11429
5 EXTRACTED XBRL INSTANCE DOCUMENT d168140d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211007414
SIC: 2834 Pharmaceutical Preparations